Search This Blog

Thursday, November 7, 2019

Dicerna Pharmaceuticals EPS misses by $0.17, misses on revenue

Dicerna Pharmaceuticals (NASDAQ:DRNA): Q3 GAAP EPS of -$0.45 misses by $0.17.
Revenue of $8.04M (+422.1% Y/Y) misses by $3.73M.
Cash, Cash Equivalents, and Marketable Securities of $312.7M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)